pain, discomfort and nausea associated with NG Tube insertion. Complications of action on the digestive system
Conditions
Interventions
Intervention 1: Intervention group, before planting NG tube, 10 mg metoclopramide (manufacturing pharmaceutical company Al-Hawi) will be given intravenously 15 minutes before the procedure. The pipeli
Treatment - Drugs
Intervention group, before planting NG tube, 10 mg metoclopramide (manufacturing pharmaceutical company Al-Hawi) will be given intravenously 15 minutes before the procedure. The pipeline project done
control group, with a similar volume of saline (as a placebo) will be administered.The pipeline project done by students trained and at zero, 30 and 60 minutes on the completed list .
Sponsors
Mazandaran University Of Medical Science
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: inclusion criteria:patient's willingness to participate in the study and obtain informed consent; Indications put nasogastric tube; Age over 18 years. exclusion criteria:Lack of patient awareness; Patients with unstable hemodynamic status; Having nosebleeds during the study period; Having problems anatomical nose; Trauma patients; Hypersensitivity to metoclopramide; Medications interact with metoclopramide; Pregnancy;patients with nausea and vomiting will ; If more than two attempts for nasogastric tube insertion is done.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Discomfort during intubation. Timepoint: Zero minutes, 30 minutes, 60 minutes. Method of measurement: score pain, nausea, discomfort.;Nausea and vomiting. Timepoint: Zero minutes, 30 minutes, 60 minutes. Method of measurement: score pain, nausea, discomfort.;Pain. Timepoint: Zero minutes, 30 minutes, 60 minutes. Method of measurement: score pain, nausea, discomfort. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Hajizadeh
Mazandaran Univercity Of Medical Science
Outcome results
None listed